The Virus Platform provides packaging services for a variety of viral types including retrovirus, lentivirus, adenovirus, adeno-associated virus (AAV). The viral titer and purity are guaranteed for effective infection for both cultured cells and tissues. The lead time for virus packaging ranges from 1 month to 3 months.

Adeno-associated virus (AAV) is a small virus which infects humans and some other primate species. AAV is not currently known to cause disease. Moreover, virus infection causes a very mild immune response. AAV can infect both dividing and non-dividing cells These features make AAV a very attractive candidate for creating viral vectors for gene therapy, and for the creation of isogenic human disease models. Recent human clinical trials using AAV for gene therapy in the retina have shown promise. Different AAV serotypes have demonstrated patterns for the target genes in terms of expression time and host selectivity. The Biowit virus platform provides a variety of AAV2 serotypes including AAV2/1, AAV2/2, AAV2/3, AAV2/4, AAV2/5, AAV2/6, AAV2/7, AAV2/8 and AAV2/9. The titer of packaged AAV  ranges from 1x10¹¹-1x 10¹² vg/ml.

Biowit Technologies Ltd. is a high-tech company specialized in providing R&D services and related products in the biological field. As a technology-driven and customer-focused company, BioWit provides a broad and integrated service and product portfolio including molecular biology, virus packaging (e.g., adenovirus, AAV, lentivirus, retrovirus and baculovirus), protein expression, cell biology, stem cells and transgenic models. One of the milestones achieved by Biowit is its recent sucess in the development of a series of serum-containing media as well as serum-free or animal -free media for stem cell culture, which are tailored for clinical applications. The core technology team members have engaged in research and development for many years in world-famous academic institutions or prestigious drug companies. Biowit has established collaboration with international prestigious research institutions. The worldwide collaboration enables Biowit to timely renew its biotechnologies (http://www.biowit.com).